| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Aug 21, 2024 | Quince Therapeutics, Inc. | COO | Buy | 91.3 | +38,924 | 15.11% | ✗ | $24.2K |
| Aug 8, 2023 | Aug 9, 2023 | Quince Therapeutics, Inc. | Chief Business Officer | Buy | 95.0 | +71,762 | 55.29% | ✗ | $87.5K |